Efficacy and Safety of DA5221-T When Added to Ongoing DA5221-B1 and DA5221-B2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control
Clinical trial NCT06290349 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06290349
- Sponsor
- Dong-A ST Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-01
- Primary completion
- 2025-09-05
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.